On July 29, 2024, the Company entered into a lease agreement for new office space in Vancouver, British Columbia. This office occupies approximately 2,243 square feet with a monthly basic rental rate and operating charges of an estimated C$ 12,296 for the two-year term of the agreement.

filing / Sep 9, 2026 / receipt

As of August 31, 2026, we no longer occupy executive office space. Our website is https://www.inmedpharma.com. The information that is contained on, or that may be linked to or accessed through our website, is not incorporated, in whole or in part, into this Annual Report in any respect.

filing / Sep 9, 2026 / receipt

● the inability to achieve synergy and cost reduction targets assumed at the time of acquisition; ● difficulties in maintaining customer and key supplier relations, including changing contract manufacturers as a result of lower volumes of business; ● the potential loss of key employees of the acquired businesses, including as a result of cultural differences between the acquired company and our own; ● the diver

filing / Sep 9, 2026 / receipt

The implementation of cost containment measures or other healthcare reforms may compromise our ability to generate revenue, attain profitability or commercialize our products.

filing / Sep 9, 2026 / receipt

The increase is primarily due to higher legal expenses and severance expenses, offset by a decrease primarily in patent fees, and

filing / May 6, 2026 / receipt

into a lease agreement for office space in Vancouver, British Columbia. This office occupies approximately 2,243 square feet with a monthly

filing / May 6, 2026 / receipt